Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in PBYI — Puma Biotechnology, Inc.

CIK 1056288 PITTSBURGH, PA
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,033,712
+$514,714 QoQ
Shares Held
250,766
+5.5% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. PBYI ranks #87 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 719,905 $216,713,000
2 RYTM
Rhythm Pharmaceuticals, Inc.
 1,785,716 $198,268,046
3 REGN
Regeneron Pharmaceuticals, Inc.
 256,884 $160,177,448
4 MRNA
Moderna, Inc.
 1,794,778 $125,688,301
5 KYMR
Kymera Therapeutics, Inc.
 749,398 $85,933,468
6 EYPT
EyePoint, Inc.
 5,681,052 $81,239,042
7 ARGX
Argenx SE
 87,288 $80,983,187
8 ZBIO
Zenas BioPharma, Inc.
 3,116,805 $79,104,510

All Filings in PBYI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,033,712 250,766
2026-03-31 $1,518,998 237,715
2025-12-31 $1,415,249 237,857
2025-09-30 $1,051,279 197,981
2025-06-30 $694,009 202,335
2025-03-31 $594,847 200,962
2024-12-31 $499,105 163,641
2024-09-30 $408,453 160,178
2024-06-30 $522,359 160,233
2024-03-31 $852,897 160,924
2023-12-31 $699,468 161,540
2023-09-30 $478,504 181,941
2023-06-30 $642,251 181,941
2023-03-31 $590,384 191,063
2022-12-31 $1,481,692 350,282
2022-09-30 $842,222 355,368
2022-06-30 $1,000,683 351,117
2022-03-31 $980,521 340,459
2021-12-31 $933,635 307,117
2021-09-30 $2,083,393 297,203
2021-06-30 $2,479,765 270,127
2021-03-31 $2,631,553 270,736
2020-12-31 $3,122,558 304,343
2020-09-30 $4,428,268 438,877
2020-06-30 $4,863,154 466,266
2020-03-31 $8,515,090 1,008,897